Jingxing Yang

1.0k total citations
27 papers, 800 citations indexed

About

Jingxing Yang is a scholar working on Immunology, Molecular Biology and Biomedical Engineering. According to data from OpenAlex, Jingxing Yang has authored 27 papers receiving a total of 800 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 12 papers in Molecular Biology and 8 papers in Biomedical Engineering. Recurrent topics in Jingxing Yang's work include Nanoplatforms for cancer theranostics (8 papers), Immunotherapy and Immune Responses (6 papers) and Immune Cell Function and Interaction (5 papers). Jingxing Yang is often cited by papers focused on Nanoplatforms for cancer theranostics (8 papers), Immunotherapy and Immune Responses (6 papers) and Immune Cell Function and Interaction (5 papers). Jingxing Yang collaborates with scholars based in China, Taiwan and United States. Jingxing Yang's co-authors include Chunfu Zhang, Wenshe Sun, Mengfei Hou, Liqin Xiong, Yimin Chai, Tsung‐Hsien Chuang, Qinghe Wu, Huilan Su, Xiaowen Liang and Jia Xu and has published in prestigious journals such as SHILAP Revista de lepidopterología, ACS Nano and Advanced Functional Materials.

In The Last Decade

Jingxing Yang

25 papers receiving 795 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jingxing Yang China 14 486 241 224 196 176 27 800
Yunfei Yi China 11 504 1.0× 256 1.1× 141 0.6× 227 1.2× 135 0.8× 17 721
Yesi Shi China 14 539 1.1× 383 1.6× 129 0.6× 225 1.1× 83 0.5× 23 958
Huapan Fang China 19 498 1.0× 448 1.9× 255 1.1× 127 0.6× 100 0.6× 43 1.1k
Jie Zang China 17 481 1.0× 341 1.4× 234 1.0× 117 0.6× 66 0.4× 28 838
Adam Yuh Lin United States 15 454 0.9× 377 1.6× 320 1.4× 165 0.8× 79 0.4× 39 988
Mixiao Tan China 13 442 0.9× 260 1.1× 124 0.6× 141 0.7× 78 0.4× 21 735
Xiaoyue Shi China 6 363 0.7× 275 1.1× 421 1.9× 106 0.5× 68 0.4× 14 829
Vladimir Mulens‐Arias Spain 14 278 0.6× 204 0.8× 239 1.1× 153 0.8× 44 0.3× 24 753
Yumin Wu China 17 282 0.6× 206 0.9× 378 1.7× 64 0.3× 107 0.6× 53 898
Jinxing Xia China 14 500 1.0× 415 1.7× 315 1.4× 141 0.7× 65 0.4× 28 1.1k

Countries citing papers authored by Jingxing Yang

Since Specialization
Citations

This map shows the geographic impact of Jingxing Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingxing Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingxing Yang more than expected).

Fields of papers citing papers by Jingxing Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jingxing Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingxing Yang. The network helps show where Jingxing Yang may publish in the future.

Co-authorship network of co-authors of Jingxing Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Jingxing Yang. A scholar is included among the top collaborators of Jingxing Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jingxing Yang. Jingxing Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xiao, Zhen, Lin Wang, Jingxing Yang, et al.. (2025). Engineered T cells stimulate dendritic cell recruitment and antigen spreading for potent anti-tumor immunity. Cell Reports Medicine. 6(9). 102307–102307. 1 indexed citations
2.
Xiao, Zhen, Jiajia Wang, Jingxing Yang, et al.. (2025). Dendritic cells instruct T cell anti-tumor immunity and immunotherapy response. 3(2). 100128–100128. 4 indexed citations
3.
Zhao, Xiang, Feng Liu, Chunhui Ma, et al.. (2025). Targeting p21‐Positive Senescent Chondrocytes via IL‐6R/JAK2 Inhibition to Alleviate Osteoarthritis. Advanced Science. 12(11). e2410795–e2410795. 3 indexed citations
4.
Tseng, Jen‐Chih, Jingxing Yang, Yiling Liu, et al.. (2024). Cooperative tumor inhibition by CpG-oligodeoxynucleotide and cyclic dinucleotide in head and neck cancer involves T helper cytokine and macrophage phenotype reprogramming. Biomedicine & Pharmacotherapy. 181. 117692–117692.
5.
Yang, Jingxing, Yu-Chen Chuang, Jen‐Chih Tseng, et al.. (2024). Tumor promoting effect of PDLIM2 downregulation involves mitochondrial ROS, oncometabolite accumulations and HIF-1α activation. Journal of Experimental & Clinical Cancer Research. 43(1). 169–169. 7 indexed citations
6.
Yang, Jingxing, et al.. (2023). Biomedical applications of artificial exosomes for intranasal drug delivery. Frontiers in Bioengineering and Biotechnology. 11. 1271489–1271489. 13 indexed citations
7.
Tseng, Jen‐Chih, Jingxing Yang, Chia‐Yin Lee, et al.. (2023). Induction of Immune Responses and Phosphatidylserine Exposure by TLR9 Activation Results in a Cooperative Antitumor Effect with a Phosphatidylserine-targeting Prodrug. International Journal of Biological Sciences. 19(9). 2648–2662. 4 indexed citations
8.
Zhang, Yanan, Jingxing Yang, Tinghao Zhang, & Hongchen Gu. (2023). Emerging advances in nanobiomaterials-assisted chimeric antigen receptor (CAR)-macrophages for tumor immunotherapy. Frontiers in Bioengineering and Biotechnology. 11. 1211687–1211687. 21 indexed citations
9.
Yang, Jingxing, Jen‐Chih Tseng, Chia‐Yin Lee, et al.. (2023). TLR9 and STING agonists cooperatively boost the immune response to SARS-CoV-2 RBD vaccine through an increased germinal center B cell response and reshaped T helper responses. International Journal of Biological Sciences. 19(9). 2897–2913. 10 indexed citations
10.
Zhang, Pengli, Qinghe Wu, Jingxing Yang, et al.. (2022). Tumor microenvironment-responsive nanohybrid for hypoxia amelioration with photodynamic and near-infrared II photothermal combination therapy. Acta Biomaterialia. 146. 450–464. 37 indexed citations
11.
Sun, Wenshe, Jingxing Yang, Mengfei Hou, et al.. (2021). A Nano “Immune‐Guide” Recruiting Lymphocytes and Modulating the Ratio of Macrophages from Different Origins to Enhance Cancer Immunotherapy. Advanced Functional Materials. 31(23). 34 indexed citations
12.
Cai, Biao, Mengfei Hou, Shijun Zhang, et al.. (2021). Dual Targeting of Endoplasmic Reticulum by Redox-Deubiquitination Regulation for Cancer Therapy. International Journal of Nanomedicine. Volume 16. 5193–5209. 16 indexed citations
13.
Tseng, Jen‐Chih, Jingxing Yang, Yiling Liu, et al.. (2021). Sharpening up tumor microenvironment to enhance the efficacy of immune checkpoint blockade on head and neck cancer using a CpG-oligodeoxynucleotide. Cancer Immunology Immunotherapy. 71(5). 1115–1128. 12 indexed citations
14.
Yang, Jingxing & Chunfu Zhang. (2020). Regulation of cancer‐immunity cycle and tumor microenvironment by nanobiomaterials to enhance tumor immunotherapy. Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology. 12(4). e1612–e1612. 47 indexed citations
15.
Zhou, Mi, et al.. (2020). Marein ameliorates Ang II/hypoxia‐induced abnormal glucolipid metabolism by modulating the HIF‐1α/PPARα/γ pathway in H9c2 cells. Drug Development Research. 82(4). 523–532. 13 indexed citations
16.
Liu, Yanlei, Jingxing Yang, Bin Liu, et al.. (2020). Human iPS Cells Loaded with MnO2-Based Nanoprobes for Photodynamic and Simultaneous Enhanced Immunotherapy Against Cancer. Nano-Micro Letters. 12(1). 127–127. 42 indexed citations
17.
Yang, Chengcheng, Huilan Su, Jingxing Yang, et al.. (2019). GE11-PDA-Pt@USPIOs nano-formulation for relief of tumor hypoxia and MRI/PAI-guided tumor radio-chemotherapy. Biomaterials Science. 7(5). 2076–2090. 34 indexed citations
18.
Yang, Jingxing, Huilan Su, Wenshe Sun, et al.. (2018). Dual Chemodrug-Loaded Single-Walled Carbon Nanohorns for Multimodal Imaging-Guided Chemo-Photothermal Therapy of Tumors and Lung Metastases. Theranostics. 8(7). 1966–1984. 77 indexed citations
19.
Cai, Jiali, Huilan Su, Jingxing Yang, et al.. (2017). Feasibility of USPIOs for T1-weighted MR molecular imaging of tumor receptors. RSC Advances. 7(50). 31671–31681. 6 indexed citations
20.
Yang, Jingxing, Yi‐Ling Chen, Chien‐Kuo Lee, et al.. (2017). Phosphodiesterase 4B negatively regulates endotoxin-activated interleukin-1 receptor antagonist responses in macrophages. Scientific Reports. 7(1). 46165–46165. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yunfei Yi Breakdown of academic impact, for papers by Yesi Shi Breakdown of academic impact, for papers by Huapan Fang Breakdown of academic impact, for papers by Jie Zang Breakdown of academic impact, for papers by Adam Yuh Lin Breakdown of academic impact, for papers by Mixiao Tan Breakdown of academic impact, for papers by Xiaoyue Shi Breakdown of academic impact, for papers by Vladimir Mulens‐Arias Breakdown of academic impact, for papers by Yumin Wu Breakdown of academic impact, for papers by Jinxing Xia
Rankless by CCL
2026